Saturday, December 10, 2011

The European Association of Hospital Pharmacists (EAHP) announces new publisher for the European Journal of Hospital Pharmacy


The European Association of Hospital Pharmacists (EAHP) announces a new partnership with the BMJ Group to publish the peer review journal European Journal of Hospital Pharmacy: Science and Practice (EJHP), launching in January 2012.



The existing journals EJHP Science and EJHP Practice will be combined to make the new journal.

Learn more about this exciting development from the EAHP President and Editor in Chief.

Benefits provided by the new journal include:

· Knowledge – the journal will concentrate on scientific content which will help you in your daily practice and professional content which will develop your career
· In-depth – coverage of all aspects of hospital pharmacy including clinical, therapeutic, economic and social disciplines giving you the full picture
· Ease – all the information that you require will be in one easy to read journal saving you time

EJHP will become more and more an educational tool answering the emerging questions of the pharmacy profession and will also continue to give updated information on professional and political developments.

Find out what the EAHP President’s views are on this new exciting development.

To submit a new paper, become a reviewer or for further information, please visit ejhp.bmj.com.


Source

EAHP

Monday, October 17, 2011

Connectathon 2012 to be held in Bern, Switzerland


More than 300 IT professionals from 70 companies are expected to attend the Twelfth Annual IHE Conntectathon, to be held next year at the Bern Expo in Bern, Switzerland from May 21 to May 25.

The decision to bring the Connectathon in Switzerland is a fantastic opportunity for stakeholders to move eHealth activities forward in our country and to continue to make interoperability progress in Europe,” said Christian Hay, user Co-Chair of IHE Suisse.


[See also: Connectathon expands to weeklong program]

The event is an intensive “connectivity marathon” for testing the interoperability of health information systems. Companies implementing IHE Technical Framework Profile specifications in their products will have a chance to test their applications with systems from other vendors.

Connectathon will also offer a full program of workshops and meetings, bringing together stakeholders from European health IT projects. In addition, a major eHealth day conference will be held on May 24.

Results from Connectathon are published on the IHE-Europe website. Vendors are able to refer to the IHE Integration Statements to show compliance of their products with IHE Integration Profiles.

[See also: IHE pharmacy trials a 'step forward' for medication integration ]


Sources

Healthcareitnews.com

http://gazelle.ihe.net/content/ihe-european-connectathon-2012

http://www.ihe.net/

http://www.ihe-europe.net/connectathon/133/cat-2012

Friday, September 30, 2011

The European Journal of Hospital Pharmacy: Science and Practice


The European Association of Hospital Pharmacists (EAHP) announces a new partnership with the BMJ Group to publish the peer review journal European Journal of Hospital Pharmacy: Science and Practice (EJHP), launching in January 2012.

The existing journals EJHP Science and EJHP Practice will be combined to make the new journal.

Learn more about this exciting development from the EAHP President and Editor in Chief.

Benefits provided by the new journal include:

· Knowledge – the journal will concentrate on scientific content which will help you in your daily practice and professional content which will develop your career

· In-depth – coverage of all aspects of hospital pharmacy including clinical, therapeutic, economic and social disciplines giving you the full picture

· Ease – all the information that you require will be in one easy to read journal saving you time

EJHP will become more and more an educational tool answering the emerging questions of the pharmacy profession and will also continue to give updated information on professional and political developments.

Find out what the EAHP President’s views are on this new exciting development.

To submit a new paper, become a reviewer or for further information, please visit ejhp.bmj.com.

Please note: authors who have submitted papers after 1st September 2011 to EJHP Science or EJHP Practice will need to re-submit to EJHP: Science and Practice using the new Instructions for Authors.

Sources

http://www.eahp.eu/

http://journals.bmj.com/site/marketing/ejhp/index.xhtml

Friday, September 09, 2011

Strategy to Better Protect Public Health by Strengthening and Rationalising EU Pharmacovigilance

Public consultation on a concept paper on implementing measures for the performance of pharmacovigilance activities
 
In order to harmonise the performance of the new pharmacovigilance activities introduced by the amended pharmacovigilance legislation (cf. Regulation (EU) No 1235/2010 and Directive 2010/84/EU) the Commission shall adopt several implementing measures. Those measures supplement essential details of the new pharmacovigilance system with the more technical details that have to be observed by marketing authorisation holders, national competent authorities and the European Medicines Agency in the daily practice of applying the new provisions.

With the public consultation the European Commission intends to describe the scope and content of the implementing measure which it is currently considering and seeks views and feedback from stakeholders on those issues. A more detailed description can be found in the concept paper pdf - 109 KB [109 KB] .

The period of consultation ends on 7 November 2011. All citizens and organisations (public and private) are welcome to contribute to this consultation. For more information on how to contribute, please read the concept paper.

Received contributions will be published on the internet. For more information on the processing of personal data in the context of this consultation, read the specific Privacy Statement pdf - 16 KB [16 KB] .

Sources

Public Health

Pharmanews

Saturday, July 02, 2011

Who Owns Patient Data?


If nature has made any one thing less susceptible than all others of exclusive property, it is the action of the thinking power called an idea, which an individual may exclusively possess as long as he keeps it to himself; but the moment it is divulged, it forces itself into the possession of every one, and the receiver cannot dispossess himself of it. Its peculiar character, too, is that no one possesses the less, because every other possesses the whole of it. He who receives an idea from me, receives instruction himself without lessening mine; as he who lights his taper at mine, receives light without darkening me. -- Thomas Jefferson

Topic 3 on the June 20 #HITsm Tweetchat got into discussions of who owns patient data. The moral high ground today seems to be towards "patient ownership."  Reality is just a bit different, and I think the discussion of ownership is not all that useful.  It should be about rights and responsibilities with respect to patient data, rather than a discussion of ownership.  My statement on this is remarkably similar to a post made by Dave Hitz on his blog.

With all due respect to patient advocates who claim ownership of the data, I don't see this enshrined in law, nor do I think "ownership" should be.  The challenge to think about are the needs of providers, who collect and organize this data to run their practices. The existence and organization of that data is essential to their practice.  Could you imagine the merger, acquisition or other disposition of a healthcare provider practice where the data they used to operate didn't go with the business?  Would that benefit patients? Almost certainly not.

What I do see in regulation is the right to obtain the data that a provider has on me (or you).  If you think about it, data is something easily shared.  After all, it's pretty easy to make copies of information, as Jefferson alludes to in the above quote.

As of now, the HIPAA Privacy regulation gives patients the right to access their information under 45 CFR §164.524 and the right to amend it under 45 CFR §164.526. Providers have the responsibility to make it available and to amend it as appropriate subject to review by the provider (with respect to accuracy,  appropriateness and source).  There are a lot of caveats here which clearly need to be change.  Provisions of this regulation are the cause of Regina Holliday's 73¢ Mural.

HITECH and Meaningful Use change that, but they assert it as a provider responsibility, rather than a patient right.  Providers that want to obtain Meaningful Use incentives have to provide patients with an electronic copy of their record within three business days of the request (instead of the 30 allotted by HIPAA) for at least 50% of patients making the request.  This is a pretty low bar.

I'm certainly in agreement with the majority that believe patients should have better rights to their data than currently available in law or regulation, but when we talk about ownership, it only confuses the issue.

Keith W. Boone is a Standards Geek for GE Healthcare. He is a member of the HL7 Board, and co-chairs the Patient Care Coordination Planning Committee for Integrating the Healthcare Enterprise. Keith writes regularly on his blog about Healthcare Standards.


Source

June 22, 2011 | Keith W. Boone
http://www.healthcareitnews.com/blog/who-owns-patient-data

Sunday, June 26, 2011

Guidelines for Good Pharmaceutical Practice from FIP and WHO






The International Pharmaceutical Federation first adopted the guidelines for Good Pharmaceutical Practice in 1993. These guidelines were developed as a reference to be used by national pharmaceutical organisations, governments, and international pharmaceutical http://www.fip.org/programmes_projects?page=good_pharmacy_practice to set up nationally accepted standards of Good Pharmacy Practice.
The revised version of this document was endorsed by WHO in 1997 and subsequently approved by the FIP Council in 1997. The GPP Guidelines are based on the pharmaceutical care given by pharmacists. The guidelines recommend for national standards to be set:
  • The promotion of health;
  • The supply of medicines, medical devices, patient self-care;
  • Improving prescribing and medicine use by pharmacists’ activities.
These guidelines have been subsequently adapted and adopted in a wide number of developed countries. In certain cases, the national professional body has strived to adapt the guidelines and developed, in collaboration with the government, specific regulation/legislation on this matter.
Conscious of the need to help developing countries achieve GPP, the FIP Community Pharmacy Section Executive Committee established a working group to produce guidelines in this area in 1992. The paper, entitled “GPP in Developing Countries – Guidelines for Implementation”, was endorsed by the FIP CPS Executive Committee in September 1998.
Having realized the importance of continuing to increase awareness of GPP and stimulating its implementation, the FIP Bureau decided to request the BPP to focus on the theme and to develop a specific activity.
Two countries had been identified as pilot sites for GPP technical assistance to the implementation of these guidelines.

GPP update 2009-2010

The year 2009 was a transition year from the current procedure to the new procedure with regards to preparing FIP Statements of Policy, including the update of the Statement on Good Pharmacy Practice. The FIP Bureau has developed a new process in order to involve FIP's Member Organisations more intensely at an earlier stage of the drafting process by introducing an extra step of producing a reference paper.
As such, on 8 September 2009 at the FIP Congress in Istanbul the Council adopted a new Reference Paper on Good Pharmacy Practice. This paper is being used as the basis for renewal of the Good Pharmacy Practice Statement, a draft of which will be proposed to the Council at the FIP Congress Lisbon 2010.
The Working Group on the Reference Paper on Good Pharmacy Practice consisted of the following members:

Prof. Henri R. Manasse, Jr. Co-chair
Dr Dick F.J. Tromp, Co-chair
Dr Lowell Anderson
Mr Colin R. Hitchings
Ms Eeva Teräsalmi
Mr Raj Vaidya
Ms Jacqueline Surugue
Dr Frans van de Vaart
Ms Marthe Everard
Mr Ton Hoek - ex officio
Prof. Phil J. Schneider - ex officio


Previous Documents: 

Good Pharmacy Practice in Developing Countries: Recommendations for step-wise implementation

Developing Pharmacy Practice

In addition to the FIP involvement in Good Pharmacy Practice through these Guidelines, FIP together with WHO has published a joint handbook entitled "Developing pharmacy practice - A focus on patient care".

This handbook sets out a the new paradigm for pharmacy practice. Its aim is to
guide pharmacy educators in pharmacy practice, to educate pharmacy students and to guide pharmacists in practice to update their skills. The handbook, which brings together practical tools and knowledge, has been written in response to a need to define, develop and generate global understanding of pharmaceutical care at all levels.

Click here to download the English version: "Developing pharmacy practice - A focus on patient care"
Click here to download the French version: "Élargir la pratique pharmaceutique - Recentrer les soins sur les patients"
Click here to download the Spanish version: "Desarrollo de la práctica de farmacia - Centrada en la atención del paciente"
Click here to download the Russian version: "Развитие фармацевтической практики: фокус на пациента"
Click here to download the Chinese version: "开展药学实践 以患者为中心"

Source